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by Elsevier B.V. This is an open accesAbstract Background and objectives: To examine the frequency of endocrinopathies in chil-
dren with systemic lupus erythematosus (SLE) and juvenile idiopathic arthritis (JIA).
Design and setting: A cross-sectional study.
Patients and methods: A study was conducted in Saudi children with SLE and JIA who were
seen at King Faisal Specialist Hospital and Research Centre, Riyadh, between September
2013 and April 2015. All enrolled patients completed the clinical evaluation, which included
information about family history of autoimmune disease, growth parameters and tanner stage,
as well as the following assessments: vitamin D profile (parathyroid hormone and 25-OH
vitamin D levels), TSH, FT4 and total T3, thyroglobulin antibodies, thyroperoxidase antibodies,
random blood sugar, HbA1C, IGF1, IGFBP-3, LH, and FSH.
Results: A total of 42 patients, 22 with JIA and 20 with SLE, were included in the study. The
mean participant age was 12.2  5.3 years with a mean disease duration of 3.2  3.4 years.
Female gender was predominant (17 SLE, 13 JIA) in the patient population. Fifteen patients
(35.7%) presented with a family history of autoimmune disease. The most frequently detected
endocrinopathies were vitamin D insufficiency (35%) and thyroid disease (31%). Eight JIA pa-
tients and 7 SLE patients exhibited low vitamin D levels; 10 patients presented with hyperpara-
thyroidism. Thyroid dysfunction was observed in 13 patients (8 SLE, 5 JIA), and 2 patients were
found to be euthyroid (normal TSH, FT4) with positive thyroid autoantibodies. Furthermore, 7
patients presented with subclinical hypothyroidism (high TSH, normal FT4), and 4 patients pre-
sented with overt hypothyroidism (high TSH, low FT4). Seven patients (4 SLE and 3 JIA) pre-
sented with short stature due to growth hormone insufficiency (low IGF1, IGFBP-3). Two
patients exhibited delayed puberty accompanied by low LH levels. Diabetes mellitus was more
frequently observed in patients with JIA (4 patients) than in patients with SLE (1 patient).
Conclusion: Our findings demonstrated that coexistence of endocrinopathies is not uncommon
in children diagnosed with JIA and SLE. Abnormal thyroid function occurs frequently and at aersity, Rheumatology, Department of Pediatrics, MBC-58, King Faisal Specialist Hospital and Research
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120 D. Alhomaidah et al.similar rate in children diagnosed with SLE and JIA. Thus, screening for endocrinopathies,
namely thyroid disease, during the assessment of childhood SLE and JIA is worth consideration.
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Autoimmunity plays a role in many inflammatory disorders
including rheumatic diseases. Although the exact etiology
of systemic lupus erythematosus (SLE) and juvenile idio-
pathic arthritis (JIA) remains undefined, multiple etiologic
factors including genetic, environmental, and hormonal
factors might contribute to immune dysregulation and
pathogenesis [1]. Growing evidence has indicated that
vitamin D deficiency may be associated with an increased
susceptibility of developing autoimmune diseases [2].
Furthermore, patients who have been diagnosed with
autoimmune disorders have a higher probability of being
affected by a second autoimmune disorder. Endo-
crinopathies have been frequently described in patients
with autoimmune rheumatic diseases such as SLE and
Sjo¨gren’s syndrome [3e5]. Interestingly, there is evidence
suggesting that JIA shares many susceptibility loci with
other autoimmune diseases [6].
Autoimmune endocrinopathies frequently overlap with
autoimmune rheumatic diseases; the prevalence of various
autoantibodies in patients with SLE and rheumatoid
arthritis is not uncommon, indicating the importance of
screening patients with SLE and systemic rheumatic dis-
eases for the coexistence of other autoimmune diseases
[7,8]. The presence of endocrinopathies in patients with
autoimmune diseases has primarily been described in adult
patients. Reports of the coexistence of endocrinopathies
and childhood autoimmune diseases, namely childhood SLE
and JIA, are scarce. Interestingly, some of the associated
autoimmune disorders occur at a subclinical level, and the
appearance of clinical manifestations may emerge late in
the disease course [9,10].
In this study, we examined the frequency of selected
endocrinopathies in children with SLE and JIA. We
compared the results from children diagnosed with SLE to
children diagnosed with JIA. We elucidated the impact of
endocrinopathies on disease activity of childhood SLE.
2. Patients and methods
A cross-sectional study was conducted on Saudi children
diagnosed with SLE and JIA who were followed at King
Faisal Specialist Hospital and Research Centre, Riyadh,
between September 2013 and April 2015. All enrolled pa-
tients were 14 years or younger. All SLE patients met the
criteria of SLE diagnosis according to the Systemic Lupus
International Collaborating Clinic classification criteria for
systemic lupus erythematosus, and all patients diagnosed
with JIA met the diagnostic criteria of the International
League of Associations for Rheumatology [11,12]. All pa-
tients were assessed for demographic data and diseaseduration. Patients completed a clinical assessment that
addressed family history of autoimmune disease, growth
parameters, and tanner stage. They were evaluated for the
following laboratory values: vitamin D profile (parathyroid
hormone and 25-OH vitamin D levels), TSH, FT4 and total T3,
thyroglobulin antibodies (TgA), thyroperoxidase antibodies
(TPOA), random blood sugar, HbA1C, IGF1, IGFBP-3, LH, FSH,
and Celiac disease panel. We considered vitamin D insuffi-
ciency to be an autoimmune disease regardless of the un-
derlying cause, coexistence with endocrinopathies, the
sequence of the disease, or the current treatment. The
standard range in Saudi Arabia for total 25-OH vitamin D
levels established by liquid chromatography-tandem mass
spectrometry is 13e76 nmol/l, and the optimal concentra-
tion should exceed 75 nmol/l. We diagnosed patients with
vitamin D insufficiency if the 25-OH vitamin D level was below
75 nmol/l. Additionally, we considered patients to have
diabetes mellitus if the HbA1C value was greater than 0.065.
Complement (C3, C4) levels, anti-double-stranded DNA
(anti-ds DNA) antibody and anti-nuclear antibody (ANA)
were included in the analysis of patients with SLE. We also
calculated the disease activity score using the Systemic
Lupus Erythematosus Disease Activity Index (SLEDAI) [13].
All collected data were handled anonymously, and pa-
tient confidentiality was protected. Additionally, all
collected data were acquired through routine clinical care.
Informed consent was obtained from the parents of pedi-
atric patients. The proposal was approved by the Research
Affairs Council at KFSHRC.
3. Statistical methods
SAS 9.2 (SAS Institute Inc., Cary, NC, USA) software was
used for statistical analysis. The variables were compared
using 2-sample t-tests, chi-square tests, and Fisher’s exact
tests. The results are expressed as the mean  standard
deviation (SD) for continuous variables and percentages for
categorical variables. Regression analysis was carried out to
examine the influence of the variables on outcome mea-
sures. A P value of <.05 was considered statistically
significant.
4. Results
A total of 42 Saudi children, 22 with JIA, and 20 with SLE,
were included in the current study. The mean age was
12.2  5.3 years with a mean disease duration of 4.2  5.4
years. Female gender was predominant (17 SLE, 13 JIA). All
SLE patients presented with multiple organ involvement
and a mean SLEDAI score of 6  5.6. Overall, nephritis (61%)
was the most frequently detected major organ condition;
none of the SLE patients exhibited renal impairment.
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965 (normal range: <40) and an elevated anti-ds DNA level
with a mean value of 784 (normal range: 0e20). Ten pa-
tients presented with low C3 and C4 levels with mean
values of 0.6 and 0.8 (normal range: 0.9e1.8 and 0.1e0.4),
respectively. The JIA patient group was composed of 13
patients with polyarticular subtype JIA, 4 patients with
oligoarticular subtype JIA and 5 patients with systemic
onset subtype JIA. All SLE patients were treated with glu-
cocorticoids, hydroxychloroquine, and immunosuppressive
medications including cyclophosphamide, azathioprine,
and mycophenolate mofetil. In contrast, JIA patients were
treated with glucocorticoids, methotrexate, and biologic
agents including TNF-inhibitors (either etanercept or ada-
limumab) or IL-6 inhibitors (tocilizumab). The mean dose of
glucocorticoids for all patients was 0.5  0.2 mg/kg/day.
Table 1 presents the spectrum of endocrinopathies in
Saudi children with SLE and JIA.
Fifteen patients (35.7%) reported a family history of
autoimmune disease. The most common autoimmune dis-
ease among family members was hypothyroidism; other
diseases included hyperthyroidism, myasthenia gravis, SLE,
rheumatoid arthritis, diabetes mellitus, vitiligo, and
psoriasis.
The most frequently detected endocrinopathies were
vitamin D insufficiency (35%) and thyroid disease (31%).
Fifteen (8 JIA, 7 SLE) patients exhibited vitamin D insuffi-
ciency with a mean level of 51.1  33.6 nmol/l; out of these
patients, 10 had been diagnosed with secondary hyper-
parathyroidism, but none had been diagnosed with
hypoparathyroidism.
Thyroid dysfunction was detected in 13 patients (8 SLE,
5 JIA); 2 patients were identified as euthyroid with positive
thyroid autoantibodies (TgA  TPOA) and normal TSH and
FT4. Furthermore, 7 patients were diagnosed with sub-
clinical hypothyroidism as manifested by high TSH and
normal FT4. In contrast, 4 patients presented with overt
hypothyroidism characterized by high TSH and low FT4.
None of the patients in the current study exhibited
thyrotoxicosis.
Nineteen patients (11 SLE, 8 JIA) presented with short
stature for their age and gender; 7 patients (4 SLE and 3
JIA) exhibited growth hormone insufficiency as confirmed




Gender (F:M) 17:3 13:9
Family history 7 8
Thyroid disease 8 5
Euthyroid 2 0
Subclinical hypothyroidism 4 3
Overt hypothyroidism 2 2
Vitamin D insufficiency 7 8
Growth hormone insufficiency 4 3
Diabetes mellitus 1 4
Delayed puberty 1 1patient presented with celiac disease confirmed by
histopathology.
Two patients were diagnosed with delayed puberty via
clinical assessment and low LH levels. The diagnosis of
diabetes mellitus was confirmed by an elevated HbA1C value
(>6.5%) and was more frequently detected in patients with
JIA (4 patients) compared to SLE (1 patient); 2 patients
were taking low doses of glucocorticoids.
Sixteen SLE patients were found to have an active form
of the disease, characterized by a mean SLEDAI score of
6  5.6. The levels of 25-OH vitamin D were inversely
correlated with SLEDAI scores, but the correlation was not
statistically significant (P values > .05). Other variables
associated with endocrinopathy were not correlated with
the SLEDAI score.
5. Discussion
The presence of an additional autoimmune disease is
common in patients diagnosed with an autoimmune disor-
der characterized by multi-organ involvement and massive
autoantibody production such as SLE. The majority of re-
ports of endocrinopathies in children with SLE and JIA have
focused on thyroid diseases, perhaps due to the ease in
measuring thyroid hormones and thyroid antibodies. Pre-
vious reports demonstrated variable frequencies of auto-
immune thyroiditis among children diagnosed with
autoimmune diseases ranging between 5% and 44%
[5,14,15]. In contrast, other endocrinopathies such as
diabetes mellitus, delayed puberty, and short stature can
be attributed to different factors and are not commonly
studied.
In the current study, we examined the frequency of
several endocrinopathies in 42 children diagnosed with SLE
and JIA. One-third of our patients had relatives who had
been diagnosed with an autoimmune disease. As previously
reported, the prevalence of autoimmune diseases in the
relatives of children with SLE and JIA is high, indicating that
different autoimmune diseases may share common sus-
ceptibility genes [16,17]. Vitamin D insufficiency is
commonly seen in children with chronic autoimmune dis-
eases. In this study, children with SLE and JIA are equally
affected; this observation confirms and supports findings
from previous studies [18,19]. Remarkably, the frequency
of vitamin D insufficiency is comparable to the frequency of
thyroid disease in this cohort, which might indicate that
vitamin D insufficiency is not simply related to glucocorti-
coid administration and may be associated with an
increased incidence of autoimmune disease [2,20]. The
serum concentration of 25-OH vitamin D was inversely
correlated with SLE disease activity, which is consistent
with previous reports [19,21]. Ten patients were diagnosed
with hyperparathyroidism secondary to vitamin D defi-
ciency, which improved after vitamin D treatment.
Thyroid dysfunction was frequently detected in patients
in the current study, which was also described in previous
reports [8,10]. Short stature and delayed puberty are
known comorbidities of chronic inflammatory disease
due to different causes. However, in the current study,
short stature and delayed puberty were associated with
hormone insufficiency, supporting the coexistence of
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revealed a higher frequency of diabetes mellitus among
patients diagnosed with JIA compared to SLE patients; this
might be related to the presence of shared common sus-
ceptibility loci between JIA and diabetes mellitus [6].
Unfortunately, HLA typing was not performed in our
patients.
Few studies have demonstrated an association between
childhood SLE or JIA and celiac disease [22]. However, in
the current study, we identified one JIA patient with celiac
disease confirmed by histopathology.
6. Conclusion
In conclusion, our findings demonstrate that the coexis-
tence of endocrinopathies is not uncommon in children
diagnosed with JIA and SLE. Vitamin D insufficiency and
abnormal thyroid function occur frequently and at similar
rates in children diagnosed with SLE and JIA. Thus, careful
screening for possible endocrinopathies, namely thyroid
disease, during assessments of patients with childhood SLE
and JIA is worth consideration.
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